GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Natural Capsules Ltd

Natural Capsules Subsidiary Allots Rs. 94.63 Lakhs in Rights Issue

FUNDRAISE ▲ Positive Development LOW RISK
📅 Filed on BSE: 31 Jul 2026, 05:44 PM IST  ·  BSE ID: 3d19f624-1222-46a5-8135-56b62c9c0ad1
View Original BSE Filing (PDF)
💡
In Simple Terms
Natural Capsules' subsidiary is completing its rights issue by allotting new shares worth Rs. 94.63 Lakhs.
🤖 AI Summary
  • Natural Biogenex subsidiary approved allotment of 9,46,305 equity shares for Rs. 94,63,050.
  • Shares have a face value of Rs. 10/- each and are allotted at par.
  • The allotment is a result of the rights issue previously approved by the company's board.
  • This follows earlier communications regarding the subsidiary's rights issue and share dilution.
🔢 Key Numbers — exact figures from BSE filing, not rounded
Equity Shares Allotted
9,46,305
Face Value per Share
Rs. 10/-
Total Allotment Value
Rs. 94,63,050
🏢 How This Affects the Company
💰
Financial Impact
The allotment of Rs. 94,63,050 to Natural Biogenex Private Limited will increase its paid-up capital. The impact on Natural Capsules Ltd's consolidated financials will depend on its participation percentage in the rights issue.
👥 What This Means For Shareholders
✅
Action Required
No action is required from Natural Capsules Ltd shareholders regarding this specific subsidiary allotment.
👤
Who Is Affected
Shareholders of Natural Biogenex Private Limited are affected by the issuance of new equity. Natural Capsules Ltd's effective shareholding in the subsidiary may be impacted based on participation.
🔍
Management Signal
The completion of the allotment signals management's commitment to capitalising its material subsidiary via rights issue.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Confirmation of Natural Capsules Ltd's final stake in Natural Biogenex post-allotment.
Any future updates on the utilization of funds raised by Natural Biogenex.
Next financial results disclosure for consolidated impact.
LOW RISK This is a routine capital-raising event for the subsidiary, with no new risks identified.
💡 Investor Takeaway
Natural Biogenex Private Limited has completed the allotment of its rights issue, issuing 9,46,305 equity shares at Rs. 10 each, aggregating Rs. 94,63,050. This confirms capital infusion into the subsidiary.
⚖️ Strengths & Concerns

✅ Positives

  • Material subsidiary successfully completes rights issue allotment, confirming capital infusion.
  • Face value of Rs. 10/- and allotment at par indicates straightforward equity issuance terms.
📅 Company Track Record
Natural Biogenex Private Limited had previously approved a rights issue targeting Rs. 1.11 Crore. Natural Capsules Ltd's stake in the subsidiary was previously diluted to 66.78% due to non-participation.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the total value of the rights issue allotment approved for Natural Biogenex?
Natural Biogenex Private Limited has approved the allotment of equity shares aggregating Rs. 94,63,050.
How many equity shares were allotted in the rights issue by Natural Biogenex?
A total of 9,46,305 equity shares, each with a face value of Rs. 10/-, were allotted.
What is the face value of the equity shares allotted by Natural Biogenex?
The equity shares allotted by Natural Biogenex have a face value of Rs. 10/- each.
What is the date of the board meeting where the allotment was approved?
The board meeting of Natural Biogenex Private Limited where the allotment was approved was held on July 31, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.